Amicus Capital is the lead investor in Rivaara Labs' first institutional round of funding.
Luthra and Luthra Law Offices India advised Amicus Capital in this deal.
The transaction team consisted of Deepak THM (Partner), Aishini Mandal (Associate) and Ayush Gattani (Associate).
The due diligence team consisted of Deepak THM (Partner), Aishini Mandal (Associate), Abhilash Agrawal (Associate) and Srijan Srivastava (Associate).
Rivaara Labs is one of the leading testing services and research and development-focused molecular diagnostics companies.